The important fact is that PCA3 seems to be more specific for prostate cancer and not elevated due to benign prostatic hyperplasia (BPH)—unlike prostate-specific antigen (PSA) or other non-cancerous conditions [44]. Here, KLK3 is linked to prostate carcinoma.